Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database.

Title : Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database

Source : PubMed
ID : 23242482
Authors : Lee S, Monz BU, Clemens A, Brueckmann M, Lip GY
Year : 2012
Disease Category : Cardiovascular diseases
Focused Population : Not Specified
Priori/Posteriori : Priori
Single-study Generalibility? : Multiple
Score/Non-Score : Non-score
Tutorial/Method : Assessed the atrial fibrillation patients who would be eligible for anticoagulant treatment trials
Compared general demographic and patient characteristics : No
Compared disease-specific clinical characteristics : No
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : No
Real-world data sources : General Practice Research Database UK
Target Population Data Type Levels : National